Table 4.
Antimicrobial susceptibility pattern of Salmonella isolates.
| Antimicrobial agent | No. of isolates tested | Antibiogram pattern of Salmonella isolates | ||
|---|---|---|---|---|
| Resistant (%) | Intermediate (%) | Sensitive (%) | ||
| Amoxycillin (30 μg) | 23 | 4 (17.39) | 4 (17.39) | 15 (65.22) |
| Ampicillin (10 μg) | 23 | 11 (47.83) | 8 (34.78) | 4 (17.39) |
| Amoxicillin/Clavulanic acid (30 μg) | 23 | – | – | 23 (100) |
| Cephazolin (30 μg) | 23 | 2 (8.70) | 2 (8.70) | 19 (82.60) |
| Ceftazidime (30 μg) | 23 | – | 5 (21.74) | 18 (78.26) |
| Chloramphenicol (30 μg) | 23 | 7 (30.43) | 13 (56.52) | 3 (13.05) |
| Ciprofloxacin (5 μg) | 23 | 5 (21.74) | 5 (21.74) | 13 (56.52) |
| Erythromycin (15 μg) | 23 | 23 (100) | – | – |
| Gentamicin (10 μg) | 23 | – | – | 23 (100) |
| Kanamycin (30 μg) | 23 | – | 2 (8.70) | 21 (91.30) |
| Penicillin (10 μg) | 23 | 23 (100) | – | – |
| Nalidixic acid (30 μg) | 23 | – | 2 (8.70) | 21 (91.30) |
| Streptomycin (10 μg) | 23 | – | 2 (8.70) | 21 (91.30) |
| Suphamethoxazole/trimethoprim (25 μg) | 23 | 4 (17.39) | 6 (26.09) | 13 (56.52) |
| Tetracycline (30 μg) | 23 | – | – | 23 (100) |
| Vancomycin (30 μg) | 23 | 23 (100) | – | – |